310. Comparison of Integration Site Profiles Between SCID-X1 Gene Therapy Trials Using Gammaretroviral Vectors With Intact or Deleted (SIN) LTRs

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34645-7
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-Optimized IL2RG Gene and Minimal Pretransplant Conditioning

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Adenovirus Vectors With the 100K Gene Deleted and Their Potential for Multiple Gene Therapy Applications

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Gene Therapy Using Retrovirus Vectors: Vector Development and Biosafety at Clinical Trials

Uirusu. Journal of virology
Medicine
2015English

517. Data Mining Methods for Integration Site Analysis in Hematopoietic Stem Cell Gene Therapy Trials

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

93. Generation of Gene-Corrected, Vector- And Reprogramming Factor-Free iPS Cells From SCID-X1 Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Cancer Gene Therapy Using Adeno-Associated Virus Vectors

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy